This is a preview of subscription content, log in via an institution to check access.
REFERENCE
De Cock E, Krueger WA, Sorensen S, Baker T, Hardewig J, Duttagupta S, Müller E, Piecyk A, Reisinger E, Resch A.Cost-effectiveness of linezolid vs vancomycin in suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany. Infection 37: 123-132, No. 2, Apr 2009
Rights and permissions
About this article
Cite this article
Linezolid tops vancomycin for MRSA NP in Germany. Pharmacoecon. Outcomes News 578, 6 (2009). https://doi.org/10.2165/00151234-200905780-00012
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905780-00012